Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Tomer Kariv is the co-founder and Chief Executive Officer of Pontifax Venture Capital, a healthcare-focused venture firm based in Herzliya, Israel. He established the firm in 2004 and has helped build a portfolio of over 40 life sciences companies, managing more than $350 million in assets. Kariv serves on the boards of several biotechnology and medical device startups, including Keros Therapeutics and Eloxx Pharmaceuticals. Before co-founding Pontifax, he spent a decade in senior management roles at Israeli financial institutions, focusing on early investments in technology-driven enterprises. He holds a Bachelor of Arts in Economics and a Juris Doctor from Harvard University.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Tomer Kariv's primary investment focus by sector?
- Tomer Kariv primarily focuses on the Health Tech & Life Sciences sector, with all recorded portfolio companies and exits falling within this area.
- Can you name a notable exit for Tomer Kariv?
- Tomer Kariv had a notable exit in May 2017 with Otic Pharma, which was acquired by Novus Therapeutics for $7 million.
- Which company is a key part of Tomer Kariv's portfolio?
- Otic Pharma, a company focused on foam-based products for ENT disorders, is a key part of Tomer Kariv's portfolio. It was acquired in May 2017.
- When did Tomer Kariv make their most recent recorded investment?
- Tomer Kariv's most recent recorded investment was in May 2015.
- What type of funding rounds has Tomer Kariv participated in?
- Tomer Kariv has participated in B Round funding stages, with one such investment recorded.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2004 |
|---|